Conference
A single agent, phase I pharmacodynamic study of nimotuzumab (TheraClM-h-R3) in patients with advanced refractory solid tumors
Authors
Brade AM; Magalhaes J; Siu L; Oza A; Lovell S; de Borja M; Pond G; Sherman I; Hedley D; Chen E
Volume
25
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 20, 2007
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
18
ISSN
0732-183X